（May 30, 2014）Earlier this month, Wincon attended 2014 ARVO conference in Orlando for ophthalmological diseases and therapies. The natural occurring ophthalmological non-human primate (NHP) models and technical capabilities Wincon showcased at ARVO receive great responses from both pharmaceutical industry and academic institutions.
Wincon has been devoted in providing reliable and clinical-like NHP models for testing of novel ideas, drugs and/or instruments. The natural occurring ophthalmological disease models include: drusens, diabetic retinopathy, macular degeneration,cataract and other vision impairing diseases. These models are established upon professional techniques and vast NHP resource possessed throughout over ten years operation.